Psoriasis is one of the most common chronic inflammatory skin diseases, affecting 3% of the
world's population, and approximately one-third of patients with psoriasis will eventually …

The concept of psoriatic arthritis (PsA) prevention is gaining increased interest owing to the
physical limitation, poor quality of life and low remission rates that are achieved with current …

Psoriatic arthritis (PsA) increases the disease burden associated with psoriasis by further
diminishing quality of life, increasing health care costs and cardiovascular risk, and …

Psoriasis and psoriatic arthritis (PsA) are chronic immune-mediated diseases that primarily
affect the skin and joints, respectively; these diseases are also associated with high rates of …

Psoriasis vulgaris and psoriatic arthritis (PsA) are inter-related heritable diseases. Psoriatic
skin is characterized by hyperproliferative, poorly differentiated keratinocytes and severe …

Psoriasis vulgaris is a multi-factorial heritable disease characterized by severe inflammation
resulting in poorly differentiated, hyperproliferative keratinocytes. Recent advances in …

Psoriatic arthritis occurs in a subset of psoriasis patients and is therefore commonly
encountered in dermatology practice. Although its exact pathogenesis is unknown, psoriatic …

Psoriatic arthritis (PsA), a chronic inflammatory arthritis, affects about 10% of patients with
psoriasis with higher prevalence seen in patients with more extensive skin disease. Early …

Psoriatic arthritis (PsA) is an immune-mediated chronic inflammatory disease, affecting both
the skin and joints. Disease progression is associated with aberrant cytokine expression …

Psoriatic arthritis is a debilitating condition, which affects approximately one‐quarter of
psoriasis patients. Recent findings have furthered our understanding of the complex …